Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Theodore S Johnson, MD, PhD
Augusta University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Augusta University, Georgia Cancer Center
Augusta, Georgia, United States
- Emory University, Children'S Heathcare of Atlanta
Druid Hills, Georgia, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Oct 2019
- Primary completion
- 2 Aug 2026
- Completion
- 2 Oct 2027
- Last update posted
- 8 Jan 2026
- Registered enrollment
- 130
- Registry id
- NCT04049669
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.